Malivanova, T. F.
Alferova, E. V.
Ostashkin, A. S.
Astrelina, T. A.
Mazurenko, N. N.
Article History
Received: 16 August 2019
Revised: 17 October 2019
Accepted: 3 December 2019
First Online: 13 June 2020
COMPLIANCE WITH ETHICAL STANDARDS
: Conflict of interest . The authors declare that they have no conflict of interest. Statement of compliance with standards of research involving humans as subjects . All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants involved in the study.
: Malivanova T.F., e-mail: tmalivanova@yandex.ru; Alferova E.V., e-mail: skoromyslovalena@yandex.ru; Ostashkin A.S., e-mail: ostashkin@yandex.ru; Astrelina T.A., e-mail: t_astrelina@mail.ru; Mazurenko N.N., e-mail: nnmazurenko@mail.ru; Corresponding author: Malivanova T.F., e-mail: tmalivanova@yandex.ruTo cite this article:Malivanova T.F., Alferova E.V., Ostashkin A.S., Astrelina T.A., Mazurenko N.N. “Breast cancer patients’ overall survival depends on a combination of the polymorphisms of tumor necrosis factor gene and HLA-haplotypes.” Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya ( Molecular Genetics, Microbiology, and Virology ), 2020, vol. 38, no. 1, pp. 4–49 (Russian).